about
Vitamin D and Inflammatory Cytokines in Healthy and Preeclamptic PregnanciesIn vivo dual targeting of the oncogenic Ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors.Regulation of calcitriol biosynthesis and activity: focus on gestational vitamin D deficiency and adverse pregnancy outcomes.Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: a potential new therapeutic approachMechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance.Calcitriol stimulates gene expression of cathelicidin antimicrobial peptide in breast cancer cells with different phenotype.Placental calcitriol synthesis and IGF-I levels in normal and preeclamptic pregnancies.The expression of RNA helicase DDX5 is transcriptionally upregulated by calcitriol through a vitamin D response element in the proximal promoter in SiHa cervical cells.Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells.A cis-acting element in the promoter of human ether à go-go 1 potassium channel gene mediates repression by calcitriol in human cervical cancer cells.Evidence of sexual dimorphism in placental vitamin D metabolism: Testosterone inhibits calcitriol-dependent cathelicidin expression.KCNH1 potassium channels are expressed in cervical cytologies from pregnant patients and are regulated by progesterone.Associations between insulin-like growth factor I, vascular endothelial growth factor and its soluble receptor 1 in umbilical serum and endothelial cells obtained from normotensive and preeclamptic pregnancies.IL-10 inhibits while calcitriol reestablishes placental antimicrobial peptides gene expression.Chronic moderate ethanol intake differentially regulates vitamin D hydroxylases gene expression in kidneys and xenografted breast cancer cells in female mice.Regulation of CYP27B1 and CYP24A1 gene expression by recombinant pro-inflammatory cytokines in cultured human trophoblasts.Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis.Preclinical and clinical aspects of TNF-α and its receptors TNFR1 and TNFR2 in breast cancer.Calcitriol promotes proangiogenic molecules in keratinocytes in a diabetic foot ulcer model.The role of the ovarian cycle and the effects of mitogen-induced cytokines on human prolactin gene expression in peripheral blood mononuclear cells.Negative correlation between testosterone and TNF-α in umbilical cord serum favors a weakened immune milieu in the human male fetoplacental unitCalcitriol Inhibits the Proliferation of Triple-Negative Breast Cancer Cells through a Mechanism Involving the Proinflammatory Cytokines IL-1 and TNF-Lipopolysaccharide and cAMP modify placental calcitriol biosynthesis reducing antimicrobial peptides gene expressionA single preovulatory administration of ulipristal acetate affects the decidualization process of the human endometrium during the receptive period of the menstrual cycleSynergistic Antitumorigenic Activity of Calcitriol with Curcumin or Resveratrol is Mediated by Angiogenesis Inhibition in Triple Negative Breast Cancer XenograftsProlactin decreases LPS-induced inflammatory cytokines by inhibiting TLR-4/NFκB signaling in the human placentaInnate Immune Cells and Toll-like Receptor-Dependent Responses at the Maternal-Fetal InterfaceASTEMIZOLE, AN INHIBITOR OF ETHER-À-GO-GO-1 POTASSIUM CHANNEL, INCREASES THE ACTIVITY OF THE TYROSINE KINASE INHIBITOR GEFITINIB IN BREAST CANCER CELLS
P50
Q26801481-53C2E2E9-5088-42D4-A5BF-4F3C8AC06614Q34325900-1CE08D84-F6F3-4A66-9A09-4D93541920AEQ34458016-308AEB56-D677-48E2-B413-C0D6B8EDF4ADQ35134342-81449907-8361-4E5F-BB00-D962D2C707F8Q36589865-F40B114D-4010-4B17-948F-D70215FE04B2Q37406121-AB6E7BA2-4992-4A60-A5E3-B149F1811D2CQ38174364-769BCFB1-311F-4437-B084-DCBC95AD2BE8Q38840347-6EAA36BC-FCA0-4B3F-8640-A3550F1C80E8Q38928348-C955CEFA-E6D4-426E-8046-4D55A6352E3CQ38930069-A275910F-D6F2-4194-A363-E604E5CB7203Q40664646-07D39F8B-02A8-4C79-A63D-57CD47E615B9Q42246746-E7851313-E180-4A8C-A95C-8A36EF39C0CBQ42439680-E9B06CE9-DCB9-4A52-9ABF-9362B625A3B8Q42463427-8FC4EFC3-3EBB-4EFD-AFA1-E7C47630867FQ42499145-D6452D3F-DB81-4F59-9A80-FFA052FEB0FCQ43688828-EA7E3614-D143-4A3F-BDBD-8B9D200EA7A0Q44257443-086F9116-655E-49FE-8B98-B572DCD39627Q47156631-A94F7C18-C417-4EB7-8324-4F727404B15AQ47638171-A6AAFFCB-F214-4227-A5D7-F537B6A2BB49Q47875882-86833DFB-EB80-42EE-A2C8-0FCBC37D2B06Q57804223-972D1327-E1CA-4824-AA1F-1E19CEAF604EQ64059977-4BC88DB6-233F-41EF-BD2C-1DE1FA7ED013Q87917790-9CEF8A33-13E3-4535-9A34-9BA2A7B13A07Q88515346-A8F32A2D-E3C1-4736-9711-2FE4FB3F1BC1Q91168530-13C73D44-EFF9-466E-BB5F-16A3309E46D6Q91536160-878DFEFA-1F02-46DA-89D4-8B3AF8148E97Q92256661-21187BF2-AC21-417A-B89D-CAC73B52C9DDQ92653093-957D5224-2743-4951-AC2E-57E206E43A89
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Lorenza Díaz
@en
Lorenza Díaz
@nl
type
label
Lorenza Díaz
@en
Lorenza Díaz
@nl
prefLabel
Lorenza Díaz
@en
Lorenza Díaz
@nl
P31
P496
0000-0002-5947-4222